1.45
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
840.86%
0.875
|
0.093 | 0.081 | 1.806 | 0.194 |
|
|
6.57%
1.881
|
1.765 | 1.538 | 1.304 | 1.322 |
| Benefits Costs and Expenses |
-
|
- | 1.51 | 1.276 | 0.917 |
| Costs And Expenses |
6.57%
1.881
|
1.765 | 1.51 | 1.276 | 0.917 |
| Operating Income/Loss |
39.83%
-1.006
|
-1.672 | -1.457 | 0.502 | -1.128 |
| Nonoperating Income/Loss |
97.77%
0.03
|
1.348 | 0.028 | 0.028 | 0.405 |
| Income/Loss From Continuing Operations Before Tax |
370.06%
0.875
|
-0.324 | -1.429 | 0.53 | -0.723 |
| Income/Loss From Continuing Operations After Tax |
201.23%
-0.976
|
-0.324 | -1.429 | 0.53 | -0.723 |
|
|
201.23%
-0.976
|
-0.324 | -1.429 | 0.53 | -0.723 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5.01%
3.225
|
3.071 | 2.556 | 0.008 | 2.526 |
| Diluted Average Shares |
5.01%
3.225
|
3.071 | 2.556 | 0.008 | 2.526 |
| Basic Earnings Per Share |
172.73%
-0.30
|
-0.11 | -0.56 | 0.22 | -0.29 |
| Diluted Earnings Per Share |
172.73%
-0.30
|
-0.11 | -0.56 | 0.22 | -0.29 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):